Singapore markets open in 6 hours 13 minutes
  • Straits Times Index

    3,252.37
    -15.17 (-0.46%)
     
  • S&P 500

    3,938.54
    -60.30 (-1.51%)
     
  • Dow

    33,559.10
    -388.00 (-1.14%)
     
  • Nasdaq

    11,026.20
    -213.74 (-1.90%)
     
  • BTC-USD

    16,953.04
    -137.02 (-0.80%)
     
  • CMC Crypto 200

    399.32
    -2.49 (-0.62%)
     
  • FTSE 100

    7,521.39
    -46.15 (-0.61%)
     
  • Gold

    1,768.70
    +1.30 (+0.07%)
     
  • Crude Oil

    73.54
    -3.39 (-4.41%)
     
  • 10-Yr Bond

    3.5550
    -0.0440 (-1.22%)
     
  • Nikkei

    27,885.87
    +65.47 (+0.24%)
     
  • Hang Seng

    19,441.18
    -77.11 (-0.40%)
     
  • FTSE Bursa Malaysia

    1,471.55
    -0.01 (-0.00%)
     
  • Jakarta Composite Index

    6,892.57
    -94.76 (-1.36%)
     
  • PSE Index

    6,674.38
    +232.25 (+3.61%)
     

4 Dividend-Paying Singapore Stocks Touching a 52-Week Low: Are They a Buy?

Malay Doctor in Hospital
Malay Doctor in Hospital

There are several ways you can go about searching for suitable investments.

One is to target growth stocks that are breaching new highs as the optimism may imply their business is doing well.

Another method is to search for cheap, value stocks that may have been unjustly beaten down due to poor sentiment.

Worries over high inflation and rising interest rates have pushed many stocks to their 52-week lows.

And for income-seeking investors, a bonus is that many of these stocks also pay out a dividend.

Here are four companies that are scraping their year-low that you can consider adding to your buy watchlist.

Frasers Property Limited (SGX: TQ5)

Frasers Property Limited, or FPL, is a property development and investment company that owns more than 1,000 properties with assets under management worth S$40.3 billion as of 30 September 2021.

FPL’s share price has declined by 11.5% in the past year to hit a 52-week low of S$1.

The property giant reported a resilient outlook during its fiscal 2022’s third quarter business update ending 30 June 2022.

Its Singapore residential launches have sold well despite cooling measures introduced by the government in December 2021.

For Riviere, FPL sold 65% of the units with target completion in the first half of fiscal 2023 (FY2023).

Planning is now in progress for Sky Eden @ Bedok for 158 residential units and 12 commercial units with a sales launch by the end of this year.

Meanwhile, over in Australia, the group secured a 2.5 million square foot site that can yield 2,150 lots of residential units.

FPL paid out a dividend of S$0.02 last year, giving its shares a trailing dividend yield of 2%.

Boustead Singapore Limited (SGX: F9D)

Boustead Singapore Limited, or BSL, is a conglomerate with four core divisions – energy-related engineering, real estate solutions, geospatial technology, and healthcare.

The group’s share price has slid to a 52-week low of S$0.84 recently, down 13.8% in the past year.

BSL reported a downbeat set of earnings for its FY2022 ending 31 March 2022 due to rising geopolitical tensions and the pandemic.

Revenue dipped by 8% year on year to S$631.8 million while net profit plunged 73% year on year to S$30.6 million.

After adjusting for one-off and exceptional items, net profit still saw a 28% year on year decline to S$32.3 million.

Despite the weaker performance, the group still declared a S$0.025 final dividend, bringing the FY2022 dividend to S$0.04, unchanged from the total ordinary dividends declared in the prior year.

The trailing dividend yield for its shares stands at 4.8%.

IHH Healthcare Berhad (SGX: Q0F)

IHH is an integrated healthcare provider that owns a portfolio of hospital brands such as Acibadem, Mount Elizabeth, Gleneagles, Fortis, Pantai, and Parkway.

The group employs more than 65,000 staff and is present in 10 countries.

IHH’s share price has fallen by close to 14% to S$1.85 after touching a 52-week low of S$1.79 recently.

The healthcare giant reported a respectable set of earnings for its fiscal 2022’s first half (1H2022).

Revenue inched up 4% year on year to RM 8.5 billion while net profit climbed by 33% year on year to RM 1.3 billion.

In Malaysia, the group agreed to sell its medical education arm, International Medical University, for an enterprise value of RM 1.35 billion.

Its Pantai Hospital Penang is also constructing a new medical block that should be ready by the end of 2024.

IHH paid out a first and final dividend of S$0.0193 last year, giving its shares a trailing dividend yield of 1%.

StarHub Ltd (SGX: CC3)

StarHub is a telecommunication (telco) group that provides mobile, internet broadband and cable TV services.

The telco’s share price has dropped by 8% in the last year to hit a 52-week low of S$1.12.

StarHub announced that total revenue for 1H2022 increased 8.7% year on year to S$1.1 billion.

However, operating and net profit declined by 8.6% and 10.3% year on year, respectively.

Despite the weaker earnings, the telco still generated S$61.2 million of free cash flow.

An interim dividend of S$0.025 was declared.

Together with its final dividend of S$0.039 for FY2021, the trailing 12-month dividend stood at S$0.064.

Shares of StarHub provide a trailing 12-month dividend yield of 5.7%.

In our special FREE report, Top 9 Dividend Stocks for 2022and 3 Tactical Shifts to Maximise Your Profits, we’re revealing 3 special categories of stocks that are poised to deliver maximum growth in 2022 and beyond.

Our safe-harbour stocks are a set of blue-chip companies that have been able to hold their own and deliver steady dividends. Growth accelerators stocks are enterprising businesses poised to continue their growth. And finally, the pandemic surprises are the unexpected winners of the pandemic.

Download for free to find out which are our safe-harbour stocks, growth accelerators, and pandemic winners! CLICK HERE to find out now!

Follow us on Facebook and Telegram for the latest investing news and analyses!

Disclaimer: Royston Yang owns shares of Boustead Singapore Limited.

The post 4 Dividend-Paying Singapore Stocks Touching a 52-Week Low: Are They a Buy? appeared first on The Smart Investor.